SG Americas Securities LLC decreased its holdings in Allstate Corporation (The) (NYSE:ALL) by 89.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,371 shares of the insurance provider’s stock after selling 68,256 shares during the quarter. SG Americas Securities LLC’s holdings in Allstate were worth $769,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also made changes to their positions in the company. Arrow Financial Corp lifted its stake in Allstate by 100.0% in the third quarter. Arrow Financial Corp now owns 1,106 shares of the insurance provider’s stock worth $102,000 after acquiring an additional 553 shares during the period. Sandy Spring Bank lifted its stake in Allstate by 2.5% in the second quarter. Sandy Spring Bank now owns 1,165 shares of the insurance provider’s stock worth $103,000 after acquiring an additional 28 shares during the period. Jackson Grant Investment Advisers Inc. raised its holdings in Allstate by 0.4% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,216 shares of the insurance provider’s stock worth $108,000 after purchasing an additional 5 shares in the last quarter. Financial Engines Advisors L.L.C. bought a new position in Allstate in the third quarter worth $116,000. Finally, IHT Wealth Management LLC raised its holdings in Allstate by 46.6% in the second quarter. IHT Wealth Management LLC now owns 1,275 shares of the insurance provider’s stock worth $113,000 after purchasing an additional 405 shares in the last quarter. 76.33% of the stock is owned by institutional investors.
Allstate Corporation (ALL) opened at $102.84 on Wednesday. Allstate Corporation has a twelve month low of $70.45 and a twelve month high of $104.10. The company has a current ratio of 0.26, a quick ratio of 0.26 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $37,181.55, a price-to-earnings ratio of 15.26, a PEG ratio of 2.00 and a beta of 1.12.
Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, November 1st. The insurance provider reported $1.60 earnings per share for the quarter, missing the consensus estimate of $1.61 by ($0.01). Allstate had a net margin of 7.32% and a return on equity of 13.11%. The company had revenue of $8.12 billion for the quarter, compared to the consensus estimate of $8.07 billion. During the same quarter in the previous year, the business earned $1.26 earnings per share. Allstate’s revenue was up 3.2% compared to the same quarter last year. sell-side analysts anticipate that Allstate Corporation will post 6.23 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Thursday, November 30th will be issued a dividend of $0.37 per share. The ex-dividend date is Wednesday, November 29th. This represents a $1.48 annualized dividend and a dividend yield of 1.44%. Allstate’s payout ratio is presently 20.56%.
In related news, EVP Susan L. Lees sold 4,000 shares of the stock in a transaction on Monday, November 20th. The stock was sold at an average price of $100.49, for a total transaction of $401,960.00. Following the sale, the executive vice president now directly owns 24,341 shares of the company’s stock, valued at $2,446,027.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Thomas J. Wilson sold 130,000 shares of the stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $99.29, for a total value of $12,907,700.00. The disclosure for this sale can be found here. Insiders have sold 432,242 shares of company stock valued at $42,827,931 over the last 90 days. Corporate insiders own 1.50% of the company’s stock.
ALL has been the subject of a number of research reports. Zacks Investment Research upgraded Allstate from a “sell” rating to a “hold” rating in a report on Friday, November 3rd. Buckingham Research initiated coverage on Allstate in a report on Monday, September 11th. They issued an “underperform” rating and a $74.00 price objective for the company. UBS increased their price objective on Allstate from $93.00 to $102.00 and gave the stock a “neutral” rating in a report on Monday, November 6th. Credit Suisse Group increased their price objective on Allstate from $91.00 to $95.00 and gave the stock a “neutral” rating in a report on Thursday, November 2nd. Finally, Wells Fargo & Company set a $105.00 price objective on Allstate and gave the stock a “buy” rating in a report on Thursday, October 19th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. Allstate has an average rating of “Hold” and an average price target of $95.08.
The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allstate Corporation (The) (NYSE:ALL).
Receive News & Ratings for Allstate Corporation (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate Corporation (The) and related companies with MarketBeat.com's FREE daily email newsletter.